Sep. 9, 2024 — Scientists developed a highly promising gene therapy to treat glaucoma -- a debilitating eye condition that can lead to complete vision loss, and which affects around 80 million ...

Unlike older male eye cells, which showed a consistent immune response pattern, older female eye cells appeared to experience ...

Gene therapy for glaucoma aims to stop and reverse vision loss associated with RGC death, by delivering neuroprotective and anti-apoptotic genes to RGCs and other support cells. However ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)1 and OXB,1 today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, gene ...

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.

The companies will work together by using the codon-optimized BBS1 AAV9 vector to minimize the vision loss caused by the genetic defects in the BBS1 gene.

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research ...

The future of glaucoma research holds tremendous potential for improving diagnosis, treatment, and patient outcomes. It is AI, gene therapy and stem cell which are revolutionizing glaucoma care by ...

Seonix Bio, a leader in the development of genetic testing for glaucoma, today announced the U.S. launch of SightScore, the first commercially available clinical polygenic risk score testing service ...

glaucoma, and diabetic eye disease. Until recently, some eye diseases had been considered incurable but new gene therapy ...